-
Product Insights
Louisiana State Univ – Our Lady of the Lake Health Interdisciplinary Science Building – Louisiana
The Louisiana State Univ – Our Lady of the Lake Health Interdisciplinary Science Building – Louisiana involves the construction of a four-story, 18,580m2 Our Lady of the Lake Health Interdisciplinary Science Building at Louisiana State University in Baton Rouge, the US. Equip yourself with the essential tools needed to make informed and profitable decisions with our Louisiana State Univ – Our Lady of the Lake Health Interdisciplinary Science Building – Louisiana report. Note: This is an on-demand report that will...
-
Track & Monitor
NewInnovation in medical: minimally invasive surgical instruments
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the medical industry’s minimally invasive surgical instruments segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge.
-
Track & Monitor
NewInternet of Things in Retail: Automated self-service kiosks
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the retail industry’s Automated self-service kiosks segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge.
-
Track & Monitor
NewExtraction technology in mining: extraction by leaching
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the mining industry’s extraction by leaching segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge.
-
Track & Monitor
NewInnovation in power: nuclear reactor cooling systems
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the power industry’s nuclear reactor cooling systems segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge.
-
Track & Monitor
NewCell & gene therapy in pharma: lentiviral vectors
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the pharma industry’s lentiviral vectors segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge.
-
Track & Monitor
NewInnovation in packaging: RFID packaging
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the packaging industry’s RFID packaging segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge.
-
Track & Monitor
NewInternet of Things in mining: remote mining vehicles
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the mining industry’s remote mining vehicles segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge.
-
Product Insights
NewNet Present Value Model: Bavarian Nordic AS’s PXVX-0317
Empower your strategies with our Net Present Value Model: Bavarian Nordic AS's PXVX-0317 report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
New
Net Present Value Model: Terns Pharmaceuticals Inc’s TERN-501
Empower your strategies with our Net Present Value Model: Terns Pharmaceuticals Inc's TERN-501 report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.